Metropolitan Health Networks CEO Discusses Q2 2012 Results - Earnings Call Transcript

Call End 12:10

Metropolitan Health Networks (MDF)

Q2 2012 Earnings Call

August 9, 2012 11:00 AM ET


Michael Earley - Chairmand & CEO

Roberto Palenzuela - General Counsel & Corporate Secretary

Bob Sabo - CFO

Joe Guethonour - President & COO


Matt Weight - Feltl and Company

Josh Raskin - Barclays

Jeff Jonas - Gabelli & Company

Gregory Macosko - Lord Abbett

Alex Clark - Apollo Capital

Matthew Nirenberg - Oppenheimer & Co



Welcome to the second quarter 2012 Metropolitan Health earnings conference call. My name is Monica and I will be your operator for today’s call. (Operator Instructions). I will now turn the call over to Michael Earley, Chairman and CEO. Earley you may begin.

Michael Earley

Thank you Monica. Good morning everyone and welcome to our call. This call is been broadcast over this conference line and is also available via the web as noted in our press release. It will be available in recorded format through the conference service and on our website. Many of you are probably noting our first use of a PowerPoint in today's presentation. We are now finally two-dimensional, we think this is an improvement and will help you better visualize our results and how we look at them. We are being the first time please bear with us, with me this morning are Dr. Joe Guethonour, President and Chief Operating Officer, Bob Sabo, our CFO and Roberto Palenzuela, our General Counsel.

A press release was issued this morning outlining our earnings for the second quarter in a quarterly report on Form 10Q will be filed with the Securities and Exchange Commission shortly. Today I will discuss the continuing growth of our company and related news. Bob will review our financial results for the quarter and first half of the year, Joe will cover some exciting news for us as we move beyond quarter with Humana. And I will close with a few comments, then we will get to Q&A.

Before we go further, let’s have Roberto cover our Safe Harbor statement.

Roberto Palenzuela

Thanks Mike. In order to comply with the forward-looking statements, Safe Harbor, I want to advise you that except for historical matters contained herein. Statements made during this conference call are forward-looking and are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limiting the generality of the foregoing, words such as may, will, to, plan, expect, believe, anticipate, intend, could, would, estimate or continue or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Investors and others are cautioned that a variety of factors including certain risks may affect our business and cause actual results to differ materially from those set forth in the forward-looking statements.

These risk factors include without limitation, the impact of our significantly increased levels of indebtedness on our funding costs, operating flexibility and ability to fund ongoing operations with additional borrowing, particularly in light of ongoing volatility in the credit and capital markets, our ability to operate pursuant to the terms of our debt obligations, are our ability to integrate the acquired operations of Continucare and to realize the anticipated revenues, economies of scale, cost synergies and productivity gains in connection with the merger and any other acquisitions that we may undertake as and when planned including the potential for unanticipated issues, expenses and liabilities associated with those acquisitions and the risk that Continucare fails meet its expected financial and operating targets.

The potential for diversion of management time and resources in seeking to integrate Continucare operations. Our ability to successfully establish a presence in new geographic markets, our ability to meet our cost projections under various provider agreements with Humana, our ability to reach an agreement to amend the new payer contract on favorable terms, our failure to accurately estimate incurred but not reported medical benefit expense. Pricing pressures exerted on us by managed care organizations and the level of payments we indirectly receive under governmental program or from other payers. Our still limited ability to predict the direct and indirect effects of the healthcare reform laws adopted in 2010, future legislation and changes in governmental regulations, the impact of Medicare risk adjustments on payments we received for our managed care operations and a loss of any of our significant contracts or our ability to increase the number of Medicare eligible patient lives we manage under these contracts.

Metropolitan is also subject to risks and uncertainties described in its filings with the Securities and Exchange Commission including its annual report on Form 10K for the year ended December 31, 2011 and its quarterly report on Form 10Q for the quarter ended June, 2012 which is expected to be filed shortly.

With that said I will turn it back to Mike.

Michael Earley

Thanks Roberto. If 2011 Metropolitan’s year, our transformational change with the acquisition of Continucare, 2012 is shaping up to be a year of growth, and some growing things. We are seeing increasing opportunities to work with Humana and other payers and helping him better manage Medicare advanced memberships and other lives as healthcare report takes root, health plans are realizing the need to align with risk providers who can deliver and who have delivered true accountable care.

A look at the graphs and pie-charts on the slide show the growth that we have achieved over the last 12 months. Growth both in terms of customer account and in terms of types of customers. The Continucare acquisition bought us both bringing new markets, additional payers and expanding our business and expertise beyond Medicare Advantage.

Read the rest of this transcript for free on